FDA Inspection 1115845 — Ingenus Pharmaceuticals GmbH
The FDA completed an inspection of Ingenus Pharmaceuticals GmbH on December 3, 2019 in Barbengo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 3, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Barbengo (Switzerland)